Legend Biotech (LEGN) Operating Expenses (2019 - 2025)

Legend Biotech has reported Operating Expenses for 7 years, with the latest figure at -$138.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses changed 0.22% year-over-year to -$138.3 million; the trailing twelve-month figure through Dec 2025 stood at -$550.5 million (changed 0.03% YoY), and the FY2025 full-year result was -$550.5 million, changed 0.04% from the prior year.
• Operating Expenses for Q4 2025 stood at -$138.3 million, up from -$147.9 million in the prior quarter.
• The five-year high for Operating Expenses was -$79836.0 in Q1 2021, with the low at -$148.0 million in Q2 2024.
• Historically, Operating Expenses has averaged -$107.6 million across 5 years, with a median of -$123.8 million in 2023.
• Annual changes were most pronounced in 2022 — Operating Expenses tumbled 117898.15% — and 2023, when it soared 99.87%.
• Legend Biotech's Operating Expenses stood at -$103.6 million in 2021, then declined by 3.66% to -$107.4 million in 2022, then soared by 99.87% to -$134390.0 in 2023, then tumbled by 103032.67% to -$138.6 million in 2024, then climbed by 0.22% to -$138.3 million in 2025.
• The last three Operating Expenses figures came in at -$138.3 million (Q4 2025), -$147.9 million (Q3 2025), and -$130.9 million (Q2 2025), per Business Quant data.